Inscrivez-vous maintenant pour un meilleur devis personnalisé!
Fitbit has received regulatory clearance from the US Food and Drug Administration (FDA) and the EU for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib). AFib affects more than 33.5 million people across the globe. AFib increases the risk of serious complications, such as strokes which can be highly difficult to detect. The Fitbit ECG app will be available in October 2020 to Fitbit Sense users in the USA, the UK, Germany, Austria, Luxembourg, the Netherlands, Sweden, Switzerland, the Czech Republic, Poland, Belgium, Portugal, Romania, Ireland, Italy, Spain, France, Hong Kong, and India.
Tags chauds:
Santé numérique: applications technologiques
Inscrivez-vous par courriel maintenant pour le Stock de Promotion hebdomadaire
100% free, Unsubscribe any time!
Add 1: Room 605 6/F FA YUEN Commercial Building, 75-77 FA YUEN Street, Mongkok KL, HongKong Add 2: Room 405, Building E, MeiDu Building, Gong Shu District, Hangzhou City, Zhejiang Province, China
Whatsapp/Tel: +8618057156223 Tél. : + 33 (0) 3 88 88 20: 0086 571 86729517 Tel à HK: 00852 66181601
Courriel:: [email protected]
English
Pусский
Français
Español
Português
